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held on July 19 and 20, 2013 in Washington, D.C., and a subset of
the conference proceedings is presented in this supplement. The
conference served as a forum for researchers and health pro-
fessionals to network, present, and dialog on emerging nutrition
research that may prevent or delay the onset of neurologic dis-
orders, generate ideas for additional research hypotheses, and
formulate a set of practical guidelines for clinicians to use with
their patients. More than 500 attendees were present at the
conference including physicians, researchers, dietitians, and
nurses, and they enjoyed networking with each other during the
formal presentations, brain-building boot camp, and social
gatherings.
The neurodegenerative disorders of the brain that were
highlighted during the conference included Parkinson’s disease,
multiple sclerosis, and dementia, the latter being a clinical syn-
drome that results from an underlying pathology (e.g., Alz-
heimer’s disease [AD], vascular dementia, Lewy body, and
frontotemporal dementia). The prevalence of dementia between
1980 and 2009 among individuals aged 60 years in 21 global
burden of disease regions was estimated to be 35.6 million in
2010 and is predicted to reach 65.7 million in 2013 and 115.4
million in 2015 (Prince et al., 2013). The costs associated with
dementia in 2010 were $604 billion globally, and the costs in
2030 are predicted to increase by 85% (Alzheimer’s Disease
International, 2010). The aforementioned neurologic disorders
are characterized by a progressive decline in cognition and
contribute to both disability and dependence (Sousa et al., 2009,
2010), which is prompting governments to address policymaking
and planning in the context of their aging population and the
emergence of a potential dementia epidemic. However, it is not
only imperative for our health and social care systems to be
prepared for the future trajectory of prevalence and costs; we
must also seek ways to meet the needs of individuals currently
living with dementia.
Increasing evidence supports the importance of vascular factors
(e.g., hypertension, diabetes, dyslipidemia, myocardial infarction) in
the etiology of dementia and cognitive decline, and vascular lesions
have been found in most late onset cases of dementia and in
approximately half of individuals with early-onset dementia
(Carotenuto et al., 2012). Therefore, the ﬁrst day of the conference
featured globally recognized researchers who provided an update
on the interplay of genes, dietary fats, vitamins, and minerals in the
context of inﬂuencing vascular factors that modulate the risk of
developing neurologic disorders. More speciﬁcally, experts dis-
cussed apolipoprotein E in the etiology of AD, dopamine’s role in
diabetes and dementia, the inﬂuence of dietary fat and vitamin E on
AD risk, copper dyshomeostasis in AD, and the role of iron in
neurologic disorders.0197-4580  2014 Elsevier Inc.
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Open access under CC BY-NC-ND license.on brain structure and functions, the role of sleep (e.g., amyloid-b
diurnal pattern) in AD pathogenesis, and methods to slow cognitive
decline following chemotherapy. Additionally, experts discussed
the role of speciﬁc B vitamins in reducing homocysteine to prevent
brain atrophy and memory loss, and the use of a starch-based diet
for the treatment of multiple sclerosis.
The 2010 National Institute of Health’s State-of-the-Science-
Conference on Preventing Alzheimer’s Disease and Cognitive
Decline report included the following statements: “Evidence is
insufﬁcient to support the use of pharmaceutical agents or dietary
supplements to prevent cognitive decline or Alzheimer’s disease.
We recognize that a large amount of promising research is under
way; these efforts need to be increased and added to by new
understandings and innovations.” (National Institute of Health,
2010). Since individuals make decisions about dietary and life-
style behaviors on a daily basis to reduce the risk of neurologic
disease, they must act on the best evidence available to them even
when scientiﬁc consensus may not have yet been achieved.
Therefore, as we wait for the ﬁndings from ongoing studies on
antihypertensive medications, omega-3 fatty acids, physical ac-
tivity, and cognitive engagement, a set of dietary and lifestyle
guidelines for the prevention of AD was formulated by the experts
and presented to the conference attendees for their immediate
consideration and needs operating under the “precautionary
principle.”
I would like to sincerely thank the conference presenters,
members of the organizing and scientiﬁc planning committees,
and the reviewers of the manuscripts. My hope is that the infor-
mation provided in this supplement will expand the existing
knowledge in the best practices for preventing and managing
neurologic disorders and be a valuable resource for researchers
and health professionals to enrich their personal lives and to pass
along to others.Disclosure statement
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